Revisto is a pioneer AI-powered technology that simplifies the medical, legal, and regulatory review process for pharmaceutical marketing.
Revisto has raised $4.0M in total funding. The most recent round was Seed. The last funding was announced in November 2024.
Revisto's investors include Eli Lilly, LiveOak Ventures, Tau Ventures, Arkin Digital Health.
Revisto is headquartered in San Antonio, United States.
Revisto is a pioneer AI-powered technology that simplifies the medical, legal, and regulatory review process for pharmaceutical marketing.
Revisto is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Revisto — Funding & Investors." VCBacked, November 18, 2024, https://www.vcbacked.co/company/revisto. Accessed September 12, 2026.
VCBacked. (2024). Revisto — Funding & Investors. Retrieved September 12, 2026, from https://www.vcbacked.co/company/revisto
{{cite web |title=Revisto — Funding & Investors |url=https://www.vcbacked.co/company/revisto |website=VCBacked |access-date=September 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated